The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial (Q43038371)
Jump to navigation
Jump to search
scientific article published in October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial |
scientific article published in October 2010 |
Statements
1 reference
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial (English)
1 reference
S C Bae
1 reference
J T Merrill
1 reference
R Burgos-Vargas
1 reference
R Westhovens
1 reference
A Chalmers
1 reference
D D'Cruz
1 reference
D J Wallace
1 reference
L Sigal
1 reference
J-C Becker
1 reference
S Kelly
1 reference
K Raghupathi
1 reference
T Li
1 reference
Y Peng
1 reference
M Kinaszczuk
1 reference
P Nash
1 reference
1 October 2010
1 reference
1 reference
1 reference
Identifiers
1 reference